A deeper understanding of the pathways modulated by this potential biomarker of neurodevelopment and pathological conditions of mental illness may help to pave the way for novel therapies needed for multiple debilitating brain disorders, also highlighting the Ndel1 roles in epilepsy. This evidence concerns the gene NDEL1 and epilepsy.